“…Surprisingly, however, the grpN-hspMC chimera (4), which does not bind Cdc37 in our pulldown assay, nonetheless supports yeast viability. The Hsp90 binding site for Cdc37 was originally mapped to the N-terminal domain [42], but recent data from the cryo-EM structure of the Cdk4-Cdc37-hHsp90 complex [61] reveals that, in the context of the client assembly, Cdc37 makes the vast majority of its interactions with the M 1 domain of the chaperone ( Fig 7A ). Thus, although the grpN-hspMC chimera (4) lacks the cognate Hsp90 N-terminal domain, it does contain the alternate Hsp90 M 1 binding site for Cdc37 that is used in the context of client complexes.…”